Zujiang Yu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 2%
Papers in
-
- RNA modifications and cancer 16
- Gut microbiota and health 12
- Epidemiology 31
- Liver Disease Diagnosis and Treatment 20
- Hepatitis B Virus Studies 8
- Co-authors
- Zhigang Ren (35 shared papers)Ang Li (13 shared papers)Guangying Cui (17 shared papers)Ranran Sun (16 shared papers)Quancheng Kan (12 shared papers)Benchen Rao (13 shared papers)Quancheng Kan (7 shared papers)Liangjie Hong (4 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (4 papers)Frontiers in Cellular and Infection Microbiology (4 papers)Scientific Reports (3 papers)Frontiers in Pharmacology (3 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Zujiang Yu
95 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 628
- Hepatology 299
- Molecular Biology 1.7k
- Biomaterials 239
- Epidemiology 573
Countries citing papers authored by Zujiang Yu
This map shows the geographic impact of Zujiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zujiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zujiang Yu more than expected).
Fields of papers citing papers by Zujiang Yu
This network shows the impact of papers produced by Zujiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zujiang Yu. The network helps show where Zujiang Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zujiang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma Hit paper breakdown → | 2018 | 543 |
| 2 | A Metal–Polyphenol‐Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy Hit paper breakdown → | 2019 | 387 |
| 3 | 2020 | 125 | |
| 4 | 2020 | 124 | |
| 5 | 2018 | 118 | |
| 6 | 2019 | 100 | |
| 7 | 2018 | 72 | |
| 8 | 2016 | 62 | |
| 9 | 2014 | 61 | |
| 10 | 2018 | 54 | |
| 11 | 2020 | 52 | |
| 12 | 2015 | 52 | |
| 13 | 2016 | 48 | |
| 14 | 2018 | 47 | |
| 15 | 2016 | 44 | |
| 16 | 2019 | 40 | |
| 17 | 2018 | 40 | |
| 18 | 2013 | 36 | |
| 19 | 2013 | 33 | |
| 20 | 2020 | 33 |
About Zujiang Yu
Zujiang Yu is a scholar working on Molecular Biology, Epidemiology, Hepatology, Cancer Research and Oncology, having authored 101 papers that have together received 3.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (16 papers), Gut microbiota and health (12 papers), Hepatitis C virus research (11 papers), MicroRNA in disease regulation (9 papers), Hepatitis B Virus Studies (8 papers) and Liver physiology and pathology (7 papers). The work is most often cited by research in Cancer Research (628 citations), Hepatology (299 citations), Molecular Biology (1.7k citations), Biomaterials (239 citations) and Epidemiology (573 citations). Zujiang Yu has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhigang Ren, Ang Li, Guangying Cui, Ranran Sun, Quancheng Kan, Benchen Rao, Quancheng Kan, Liangjie Hong, Zhengwei Mao and Shichao Sun. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Frontiers in Cellular and Infection Microbiology, Scientific Reports, Frontiers in Pharmacology and Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.